[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Heartflow Inc (HTFL)

Heartflow Inc (HTFL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

JPMorgan Chase CEO Jamie Dimon Says AI 'Will Cure Cancers' — But How Should You Invest?

There is a lot of optimism around the potential for artificial intelligence (AI) technology, but perhaps no bolder prediction has been made than this one by JPMorgan Chase (JPM) CEO Jamie Dimon: 

"It's real ... it will cure cancers. Your children are going to live to 100."

Fundamentals

See More
  • Market Capitalization, $K 2,307,809
  • Shares Outstanding, K 86,241
  • Annual Sales, $ 176,030 K
  • Annual Income, $ -116,790 K
  • EBIT $ -69 M
  • EBITDA $ -56 M
  • 60-Month Beta N/A
  • Price/Sales 12.36
  • Price/Cash Flow N/A
  • Price/Book 7.62

Options Overview Details

View History
  • Implied Volatility 103.03% (+0.33%)
  • Historical Volatility 76.86%
  • IV Percentile 80%
  • IV Rank 36.51%
  • IV High 160.33% on 02/12/26
  • IV Low 70.08% on 06/18/26
  • Expected Move (DTE 17) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 20
  • Volume Avg (30-Day) 46
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 2,949
  • Open Int (30-Day) 3,076
  • Expected Range 27.11 to 27.11

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.22
  • Number of Estimates 2
  • High Estimate $-0.21
  • Low Estimate $-0.23
  • Prior Year $-1.46
  • Growth Rate Est. (year over year) +84.93%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.87 +14.16%
on 07/22/26
29.36 -7.19%
on 07/06/26
-0.72 (-2.56%)
since 07/02/26
3-Month
23.87 +14.16%
on 07/22/26
36.46 -25.26%
on 06/26/26
-1.70 (-5.87%)
since 05/04/26

Most Recent Stories

More News
JPMorgan Chase CEO Jamie Dimon Says AI 'Will Cure Cancers' — But How Should You Invest?

The typically bearish Dimon recently offered some wildly optimistic comments on the potential for artificial intelligence to solve one of the biggest healthcare quandaries in modern medicine.

NVDA : 212.70 (+2.93%)
HTFL : 27.44 (+2.54%)
JPM : 358.38 (+1.63%)
$SPX : 7,752.70 (+2.00%)
SKHY : 153.76 (+7.74%)
TSM : 417.95 (+2.92%)
Heartflow to Report Second Quarter 2026 Financial Results on August 13, 2026

SAN FRANCISCO, July 23, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release financial results...

HTFL : 27.44 (+2.54%)
New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management

Heartflow Plaque Staging TM , the only staging tool based on total plaque volume * , is now included with every Heartflow Plaque Analysis Data from over 36,000 patients validate the accuracy,...

HTFL : 27.44 (+2.54%)
Heartflow Q1 Earnings Call Highlights

Heartflow (NASDAQ:HTFL) reported a sharply higher first-quarter revenue total and raised its full-year 2026 outlook, citing strength in its core FFRCT business, faster-than-expected adoption of its Plaque...

HTFL : 27.44 (+2.54%)
HeartFlow: Q1 Earnings Snapshot

HeartFlow: Q1 Earnings Snapshot

HTFL : 27.44 (+2.54%)
Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance

SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the first...

HTFL : 27.44 (+2.54%)
HeartFlow's AI Diagnostics Model Faces Its First Profitability Pressure Test

Barchart Research What to Expect from HTFL Earnings HTFL Generated May 13, 2026 Current Price $31.20 EPS Estimate $$-0.24 Consensus Rating Strong Buy Average Move 6.50% HeartFlow's AI Diagnostics Model...

HTFL : 27.44 (+2.54%)
Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026

SAN FRANCISCO, April 23, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release financial...

HTFL : 27.44 (+2.54%)
Heartflow Files Patent Infringement Lawsuit Against Cleerly

MOUNTAIN VIEW, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that it has filed...

HTFL : 27.44 (+2.54%)
HeartFlow: Q4 Earnings Snapshot

HeartFlow: Q4 Earnings Snapshot

HTFL : 27.44 (+2.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

Heartflow Inc. is an AI technology for coronary artery disease. Heartflow Inc. is based in MOUNTAIN VIEW, Calif.

See More

Key Turning Points

3rd Resistance Point 29.57
2nd Resistance Point 28.45
1st Resistance Point 27.61
Last Price 27.44
1st Support Level 25.65
2nd Support Level 24.53
3rd Support Level 23.69

See More

52-Week High 41.22
Fibonacci 61.8% 33.17
Fibonacci 50% 30.68
Fibonacci 38.2% 28.19
Last Price 27.44
52-Week Low 20.13

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.